Bronchial asthma
We correct the excessive immune reaction in the respiratory tract, reducing the frequency and severity of bronchial asthma attacks.
About the disease
Bronchial asthma is a chronic inflammatory disease of the respiratory tract with episodes of difficult breathing caused by bronchial hyperresponsiveness.
Immunotherapy aims to correct the excessive immune response underlying allergic inflammation and reduce dependence on symptomatic drugs.
Cause, not symptom
Impact on the mechanism of allergic inflammation.
Fewer attacks
Reduction in the frequency and severity of exacerbations.
Disease control
Improvement of respiratory function.
Immune response correction
The goal is to retrain the immune system to adequately respond to allergens and reduce excessive hypersensitivity.
Diagnostics
Assessment of the allergen spectrum and immune system status to build an individualized plan.
Preparation
Manufacturing a personalized cellular preparation based on your immunocompetent cells.
Therapy course
Administering the preparation builds tolerance to allergens and reduces reaction intensity.
Stabilization
Long-term reduction in the frequency and severity of exacerbations without the constant use of antihistamines.
Other directions
Atopic dermatitis
Impacting the root cause of chronic skin inflammation, rather than just the external symptoms.
Allergic rhinitis
Reducing the hypersensitivity of the nasal mucosa to allergens for long-lasting relief.
Pollinosis
Control over seasonal allergy to plant pollen with a reduction in symptom severity.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.